4.1 Review

Roles of the WHHL Rabbit in Translational Research on Hypercholesterolemia and Cardiovascular Diseases

Journal

Publisher

HINDAWI LTD
DOI: 10.1155/2011/406473

Keywords

-

Funding

  1. Ministry of Health and Labor in Japan
  2. Ministry of Education, Culture, Science and Technology of Japan
  3. Sankyo Co., Ltd., Tokyo, Japan
  4. Takeda Pharmaceutical Co., Ltd., Osaka, Japan
  5. Daiich-Sankyo Co., Ltd., Tokyo, Japan
  6. Shionogi & Co. Ltd, Osaka, Japan
  7. Taisho Pharmaceutical Co. Ltd., Tokyo, Japan
  8. Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan
  9. Banyu Pharmaceutical Co. Ltd., Tokyo, Japan
  10. Nippon Shinyaku Co. Ltd., Osaka, Japan

Ask authors/readers for more resources

Conquering cardiovascular diseases is one of the most important problems in human health. To overcome cardiovascular diseases, animal models have played important roles. Although the prevalence of genetically modified animals, particularly mice and rats, has contributed greatly to biomedical research, not all human diseases can be investigated in this way. In the study of cardiovascular diseases, mice and rats are inappropriate because of marked differences in lipoprotein metabolism, pathophysiological findings of atherosclerosis, and cardiac function. On the other hand, since lipoprotein metabolism and atherosclerotic lesions in rabbits closely resemble those in humans, several useful animal models for these diseases have been developed in rabbits. One of the most famous of these is the Watanabe heritable hyperlipidemic (WHHL) rabbit, which develops hypercholesterolemia and atherosclerosis spontaneously due to genetic and functional deficiencies of the low-density lipoprotein (LDL) receptor. The WHHL rabbit has been improved to develop myocardial infarction, and the new strain was designated the myocardial infarction-prone WHHL (WHHLMI) rabbit. This review summarizes the importance of selecting animal species for translational research in biomedical science, the development of WHHL and WHHLMI rabbits, their application to the development of hypocholesterolemic and/or antiatherosclerotic drugs, and future prospects regarding WHHL and WHHLMI rabbits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available